新着動画一覧

(CPIX, GCOM, EXEL) CRWENewswire Stocks to Watch

On its Second Quarter Fiscal 2012, Globecomm Systems Inc - GCOM - posted revenue of $95.2 million, a 35.5% increase year over year. Exelixis Inc - EXEL - reported results for the fourth quarter 2011, posting revenues of $93.3 million, compared to $40.8 million for the comparable period in 2010. Cumberland Pharmaceuticals Inc - CPIX - reported that it has received a Notice of Allowance from the United States Patent and Trademark Office relating to its new formulation of Acetadote (acetylcysteine) Injection, which is used to treat acetaminophen poisoning. ********************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).

投稿者： karmastock
投稿日時：2012-02-09 11:40:39.0
視聴回数：342回
お気に入り登録：0
カテゴリ： ビジネス全般  
タグ： acetylcysteine   acetaminophen   Cumberland   Globecomm   Exelixis   GCOM   EXEL   CPIX   Nasdaq:CPIX   Nasdaq:EXEL   Nasdaq:GCOM